BMS-275183

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BMS-275183, covering 2010-03-02 to 2010-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer [Phase 2]